Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

54 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Validation of High-Risk Features for Stent-Related Ischemic Events as Endorsed by the 2017 DAPT Guidelines.
Ueki Y, Karagiannis A, Zanchin C, Zanchin T, Stortecky S, Koskinas KC, Siontis GCM, Praz F, Otsuka T, Hunziker L, Heg D, Moschovitis A, Seiler C, Billinger M, Pilgrim T, Valgimigli M, Windecker S, Räber L. Ueki Y, et al. Among authors: zanchin t, zanchin c. JACC Cardiovasc Interv. 2019 May 13;12(9):820-830. doi: 10.1016/j.jcin.2018.12.005. Epub 2019 Apr 10. JACC Cardiovasc Interv. 2019. PMID: 30981574 Free article.
Clinical impact of gastrointestinal bleeding in patients undergoing percutaneous coronary interventions.
Koskinas KC, Räber L, Zanchin T, Wenaweser P, Stortecky S, Moschovitis A, Khattab AA, Pilgrim T, Blöchlinger S, Moro C, Jüni P, Meier B, Heg D, Windecker S. Koskinas KC, et al. Among authors: zanchin t. Circ Cardiovasc Interv. 2015 May;8(5):e002053. doi: 10.1161/CIRCINTERVENTIONS.114.002053. Circ Cardiovasc Interv. 2015. PMID: 25910501 Clinical Trial.
Safety of Prasugrel Loading Doses in Patients Pre-Loaded With Clopidogrel in the Setting of Primary Percutaneous Coronary Intervention: Results of a Nonrandomized Observational Study.
Räber L, Klingenberg R, Heg D, Kelbæk H, Roffi M, Tüller D, Baumbach A, Zanchin T, Carballo D, Ostojic M, Stefanini GG, Rodondi N, von Birgelen C, Moschovitis A, Engstrøm T, Gencer B, Auer R, Meier B, Mach F, Lüscher TF, Jüni P, Matter CM, Windecker S; COMFORTABLE and SPUM-ACS Trial Investigators. Räber L, et al. Among authors: zanchin t. JACC Cardiovasc Interv. 2015 Jul;8(8):1064-1074. doi: 10.1016/j.jcin.2015.03.023. JACC Cardiovasc Interv. 2015. PMID: 26205445 Free article.
External validity of the "all-comers" design: insights from the BIOSCIENCE trial.
Franzone A, Heg D, Räber L, Valgimigli M, Piccolo R, Zanchin T, Yamaji K, Stortecky S, Blöchlinger S, Hunziker L, Praz F, Jüni P, Windecker S, Pilgrim T. Franzone A, et al. Among authors: zanchin t. Clin Res Cardiol. 2016 Sep;105(9):744-54. doi: 10.1007/s00392-016-0983-z. Epub 2016 Apr 1. Clin Res Cardiol. 2016. PMID: 27033859 Free article. Clinical Trial.
Preprocedural High-Sensitivity Cardiac Troponin T and Clinical Outcomes in Patients With Stable Coronary Artery Disease Undergoing Elective Percutaneous Coronary Intervention.
Zanchin T, Räber L, Koskinas KC, Piccolo R, Jüni P, Pilgrim T, Stortecky S, Khattab AA, Wenaweser P, Bloechlinger S, Moschovitis A, Frenk A, Moro C, Meier B, Fiedler GM, Heg D, Windecker S. Zanchin T, et al. Circ Cardiovasc Interv. 2016 Jun;9(6):e003202. doi: 10.1161/CIRCINTERVENTIONS.115.003202. Circ Cardiovasc Interv. 2016. PMID: 27296200
Duration of Triple Antithrombotic Therapy and Outcomes Among Patients Undergoing Percutaneous Coronary Intervention.
Koskinas KC, Räber L, Zanchin T, Pilgrim T, Stortecky S, Hunziker L, Blöchlinger S, Billinger M, Gartwyl F, Moro C, Moschovitis A, Jüni P, Heg D, Windecker S. Koskinas KC, et al. Among authors: zanchin t. JACC Cardiovasc Interv. 2016 Jul 25;9(14):1473-83. doi: 10.1016/j.jcin.2016.04.027. JACC Cardiovasc Interv. 2016. PMID: 27478115 Free article.
External validity of a contemporaneous primary percutaneous coronary intervention trial in patients with acute ST-elevation myocardial infarction: insights from a single-centre investigation.
Spitzer E, Hadorn S, Zanchin T, Yamaji K, Moschovitis A, Pilgrim T, Stortecky S, Jüni P, Heg D, Windecker S, Räber L. Spitzer E, et al. Among authors: zanchin t. EuroIntervention. 2016 Oct 20;12(9):1135-1143. doi: 10.4244/EIJV12I9A185. EuroIntervention. 2016. PMID: 27753599 Free article.
Derivation and validation of the predicting bleeding complications in patients undergoing stent implantation and subsequent dual antiplatelet therapy (PRECISE-DAPT) score: a pooled analysis of individual-patient datasets from clinical trials.
Costa F, van Klaveren D, James S, Heg D, Räber L, Feres F, Pilgrim T, Hong MK, Kim HS, Colombo A, Steg PG, Zanchin T, Palmerini T, Wallentin L, Bhatt DL, Stone GW, Windecker S, Steyerberg EW, Valgimigli M; PRECISE-DAPT Study Investigators. Costa F, et al. Among authors: zanchin t. Lancet. 2017 Mar 11;389(10073):1025-1034. doi: 10.1016/S0140-6736(17)30397-5. Lancet. 2017. PMID: 28290994 Review.
Postprocedural high-sensitivity troponin T and prognosis in patients with non-ST-segment elevation myocardial infarction treated with early percutaneous coronary intervention.
Harada Y, Koskinas KC, Ndrepepa G, Räber L, Braun S, Zanchin T, Kufner S, Hunziker L, Byrne RA, Heg D, Kastrati A, Windecker S. Harada Y, et al. Among authors: zanchin t. Cardiovasc Revasc Med. 2018 Jul;19(5 Pt A):480-486. doi: 10.1016/j.carrev.2017.11.010. Epub 2017 Nov 22. Cardiovasc Revasc Med. 2018. PMID: 29292015
Incidence, Predictors, and Clinical Impact of Early Prasugrel Cessation in Patients With ST-Elevation Myocardial Infarction.
Koskinas KC, Zanchin T, Klingenberg R, Gencer B, Temperli F, Baumbach A, Roffi M, Moschovitis A, Muller O, Tüller D, Stortecky S, Mach F, Lüscher TF, Matter CM, Pilgrim T, Heg D, Windecker S, Räber L. Koskinas KC, et al. Among authors: zanchin t. J Am Heart Assoc. 2018 Apr 13;7(8):e008085. doi: 10.1161/JAHA.117.008085. J Am Heart Assoc. 2018. PMID: 29654204 Free PMC article. Clinical Trial.
54 results